Results 71 to 80 of about 5,601 (170)

Kikuchi-Fujimoto disease and systemic lupus erythematosus

, 2016
Diego F Baenas,1 Fernando A Diehl,1 María J Haye Salinas,2 Verónica Riva,3 Ana Diller,3 Pablo A Lemos1,4 1Clinical Medicine Department, 2Rheumatology Department, 3Pathology Department, Hospital Privado Universitario de Córdoba ...
Baenas DF, Riva V, Diehl FA, Haye Salinas MJ, Lemos PA, Diller A   +5 more
core  

A Case Report of Kikuchi-Fujimoto Disease with Immune Thrombocytopenic Purpura [PDF]

, 2010
Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) is a rare disease characterized by lymphadenitis with fever. It is self-limited within one to four months, and is generally diagnosed by an excisional biopsy of the affected lymph node ...
강희철, 이승범, 김원용
core   +1 more source

Kikuchi-Fujimoto disease: an unusual association with acute renal failure

Brazilian Journal of Infectious Diseases, 2010
Kikuchi-Fujimoto disease, also known as histiocytic necrotizing lymphadenitis of unknown etiopathogenesis, is a self-limited disease which frequently appears as feverish lymphadenomegaly, thus creating the need for differential diagnosis with lymphoma ...
Amanda Feliciano da Silva, MD, Roberto Focaccia, MD, PhD, Allan Constantino de Oliveira, MD, Angelo Sementilli, MD, PhD, Gelvana Flávio Barreto Reis, MD   +4 more
doaj   +1 more source

Doença de Kikuchi-Fujimoto.

Acta Médica Portuguesa, 2005
Kikuchi and Fujimoto's disease, also known as histiocytic necrotizing lymphadenopathy, is a rare and benign disorder of the lymph nodes of young adults.
Alice Reichert, T Correia, O Freitas, T Almeida, Lino Rosado   +4 more
doaj   +1 more source

Kikuchi-Fujimoto disease in a young patient : a case report

, 2022
A rare form of lymphadenopathy called Kikuchi-Fujimoto disease (KFD), also known as histiocytic necrotizing lymphadenitis, was discovered in Japan in 1972 by Kikuchi and Fujimoto.
Wan Ramli, Wan Nurliyana, Hairudin, Khairee Aqil, Saidin, Amira, Abd. Fuaat, Azliana, Ibrahim, Ismail, Zainulabid, Ummu Afeera   +5 more
core  

Heterozygous germline TET2 loss‐of‐function variants associated with an ALPS‐like phenotype

British Journal of Haematology, Volume 206, Issue 5, Page 1330-1334, May 2025.
Summary Germline homozygous loss‐of‐function mutations in TET2 result in significant childhood immunodeficiency that resembles autoimmune lymphoproliferative syndrome and predisposes one to lymphoma. The implications of heterozygous variants are less well understood.
Sean Harrop, Joshua Casan, Hannah Rose, Michael Sullivan, Sam Mehr, Henry Ngu, Imogen Caldwell, Joseph McKendrick, Mary Ann Anderson, Nicole Den Elzen, Erin Goode, Lucy C. Fox, Stephen Lade, Piers Blombery   +13 more
wiley   +1 more source

Kikuchi-Fujimoto Disease as an Etiology for Relapsing/Remitting Fevers and Lymphadenopathy in a Patient With Dermatomyositis

Annals of Internal Medicine: Clinical Cases
Kikuchi-Fujimoto disease is a rare disease characterized by persistent fevers, tender lymphadenopathy, hyperinflammation, and histiocytic necrotizing lymphadenitis. It has been described in association with autoimmune disorders, primarily, systemic lupus
Danny Luan, Kavya Penmethsa, Sanjay Patel, Justin Kaner, David R. Fernandez   +4 more
doaj   +1 more source

Kikuchi–Fujimoto Disease Presenting as Brachial Plexus Neuritis: A Case Report

Indian Journal of Neurosurgery, 2016
Kikuchi–Fujimoto disease is a rare, idiopathic, self-limiting necrotizing lymphadenitis of unknown etiology. It usually affects young Asian women. Clinically, it closely resembles with tuberculosis or lymphomas.
Rakesh Gupta, Akshat Kayal, Vishwesh Rajawat   +2 more
doaj   +1 more source

A Perplexing Predominance of Plasmacytoid Dendritic Cells: Chronic Myelomonocytic Leukemia Initially Considered on a Lymph Node Biopsy

eJHaem, Volume 6, Issue 6, December 2025.
Jaryse Harris, Elena Fenu, Adam Bagg
wiley   +1 more source

Impact of the COVID‐19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single‐center retrospective study in Japan

DEN Open, Volume 5, Issue 1, April 2025.
Abstract Objectives This study aimed to determine the impact of the coronavirus disease 2019 (COVID‐19) pandemic on the treatment of acute cholangitis caused by choledocholithiasis. Methods The Japanese government declared a state of emergency in April 2020 due to the COVID‐19 pandemic.
Jun‐ichi Hanatani, Koh Kitagawa, Fumimasa Tomooka, Shohei Asada, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Shinya Sato, Akihiko Shibamoto, Yuki Fujimoto, Takahiro Kubo, Satoshi Iwai, Yuki Tsuji, Tadashi Namisaki, Takemi Akahane, Kosuke Kaji, Misako Tanaka, Aritoshi Koizumi, Nobuyuki Yorioka, Takuya Matsuda, Hiroyuki Masuda, Masayoshi Takami, Mayuko Kikuchi, Mariya Kawanishi, Kazutaka Ohoka, Daisuke Watanabe, Akane Kawasaki, Hitoshi Yoshiji   +27 more
wiley   +1 more source